NCT07035145View on ClinicalTrials.gov

Observational Cohort Study of Dysferlinopathy in China

CompletedOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

March 15, 2025

Study Completion Date

March 31, 2025

Conditions
Dysferlinopathy
Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT07035145 - Observational Cohort Study of Dysferlinopathy in China | Biotech Hunter | Biotech Hunter